The attention drawn to the secret world of rebates could hurt the profits of some of the industry’s most successful drugs. The normally closely guarded world of drug pricing is getting a very public airing in a feud between two of the industry’s biggest companies. On Wednesday, Turing Pharmaceuticals announced that it would raise prices on its blockbuster drug, Daraprim, by more than 5,000 percent to $750 per pill.
The normally closely guarded world of drug pricing is getting a very public airing in a feud between two of the industry’s biggest companies. On Wednesday, Turing Pharmaceuticals announced that it would raise prices on its blockbuster drug, Daraprim, by more than 5,000 percent to $750 per pill.